EP0593539A1 - Additiv für kulturmedium auf der basis von eisenchelaten - Google Patents

Additiv für kulturmedium auf der basis von eisenchelaten

Info

Publication number
EP0593539A1
EP0593539A1 EP92913614A EP92913614A EP0593539A1 EP 0593539 A1 EP0593539 A1 EP 0593539A1 EP 92913614 A EP92913614 A EP 92913614A EP 92913614 A EP92913614 A EP 92913614A EP 0593539 A1 EP0593539 A1 EP 0593539A1
Authority
EP
European Patent Office
Prior art keywords
citrate
culture medium
fecl
iron
iron salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP92913614A
Other languages
English (en)
French (fr)
Inventor
Peter Bernt Suhr-Jessen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Priority to EP92913614A priority Critical patent/EP0593539A1/de
Publication of EP0593539A1 publication Critical patent/EP0593539A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/005—Protein-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin

Definitions

  • Iron c elate culture medium additive Iron c elate culture medium additive.
  • the present invention relates to an iron supplement for culture media, primarily serum-free or protein-free media, for growing mammalian cells, and a culture medium containing said iron supplement.
  • the present invention relates to a culture medium additive comprising an iron chelate of a soluble iron salt and an alkali metal or alkaline earth metal citrate.
  • Iron chelates for serum-free media have previously been proposed, e.g. in EP 274 445 describing a culture medium additive containing an iron-EDTA/citric acid chelate and aurin tricarboxylic acid.
  • the iron chelate additive of the present invention has the advantage over the one proposed in EP 274 445 that it is composed of inexpensive constituents, and that it contains fewer constituents which might be a ⁇ ource of contamination.
  • the present invention relates to a culture medium for growing mammalian cells, the medium comprising an iron chelate of a soluble iron salt and an alkali metal or alkaline earth metal citrate.
  • the citrate chelator should be mixed with the iron salt so as to generate an equilibrium prior to the addition to the culture medium.
  • This equilibrium may for instance be formed in a concentrated stock solution and, and the process speeded up by stirring, autoclaving, etc.
  • the requisite equilibrium is most conveniently reached when the alkali metal or alkaline earth metal citrate is present in a molar excess relative to the iron salt, in particular a ratio of the citrate to the iron salt of more than 1:1 and less than 500:1.
  • Suitable iron salts for inclusion in the additive of the invention may be selected from the group consisting of FeCl 2 , FeCl 3 , FeS0 4 , Fe 3 (P0 4 ) 2 , Fe(N0 3 ) 3 and Fel 2 .
  • suitable alkali metal or alkaline earth metal citrates for inclusion in the additive of the invention are Na-citrate, K-citrate or Mg- citrate.
  • the iron salt included in the additive is FeCl 2 or FeCl 3
  • the citrate is Na-citrate.
  • a preferred molar ratio of Na-citrate to FeCl 2 /FeCl 3 is between 2:1 and 200:1.
  • the culture medium in which the additive i ⁇ intended to be included is preferably a medium for growing mammalian cells, the additive of the invention constituting an inexpensive iron source which mammalian cells have surprisingly been able to utilise.
  • the medium may for instance be a low-serum medium or, preferably, a serum-free or protein-free medium in which it is important to provide a non-protein iron supplement.
  • mammalian cell ⁇ may al ⁇ o utilise a citrate/iron chloride chelate as the iron source in serum- free media.
  • mammalian cells which exist in an environment enriched in nutrient components and under conditions of considerable osmotic pressure are able to assimilate nutrients in a similar way as a primitive freshwater organism specialized in surviving in a nutrient-poor environment.
  • Adherent BHK cells cultivated in coated T-flask ⁇ containing a serum-free nutrient medium for BHK cells (as described by Maciag et al. 1980, ibid) with transferrin as the only iron source (SFNMT) , were concomitantly inoculated into a series of coated T-flask ⁇ containing serum-free nutrient medium lacking transferrin (SFNM-) but supplemented with a chelated stock solution of Na-citrate and iron chloride.
  • SFNMT transferrin as the only iron source
  • BHK cells were inoculated into spinner flasks containing SFNM- for BHK cells (see example 1) supplemented with a chelated citrate-iron stock solution resulting in 2 mM Citrate and 100 ⁇ M FeCl 3 (final cone.) . Following a few hours where cells were allowed to adhere to coated microcarrier ⁇ , cells spread, propagated and remained es ⁇ entially confluent and healthy for more than two weeks when the experiment was terminated.
  • Adherent CHO cells cultivated in coated T-flasks containing a serum-free nutrient medium for CHO cells (as described by Ham et al. 1979, ibid.) with transferrin as the only iron source (SFNMT) , were concomitantly inoculated into a series of coated T-flask ⁇ containing serum-free nutrient medium lacking transferrin (SFNM-) but supplemented with a chelated stock solution of Na-citrate and iron chloride.
  • SFNMT transferrin as the only iron source
  • Each cell culture was independently treated with respect to replacement of u ⁇ ed medium with fresh serum-free medium of the identical kind or sub-cultivation into new T-flask containing fresh serum-free medium of the identical kind.
  • CHO cells were inoculated into two spinner flasks containing SFNM- for CHO cells (see example 3) supplemented with chelated citrate-iron chloride stock solutions resulting in 2 mM Citrate and 100 and 300 ⁇ M FeCl 3 (final cone), re ⁇ pectively. After a few hour ⁇ where cells were allowed to adhere to coated micro carriers, cells spread, propagated and remained essentially confluent and healthy for more than two weeks when the experiment was terminated.
  • SFNMT transferrin as the only iron source
  • SFNMT transferrin as the only iron source

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP92913614A 1991-06-21 1992-06-18 Additiv für kulturmedium auf der basis von eisenchelaten Withdrawn EP0593539A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP92913614A EP0593539A1 (de) 1991-06-21 1992-06-18 Additiv für kulturmedium auf der basis von eisenchelaten

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP91610054 1991-06-21
EP91610054 1991-06-21
PCT/DK1992/000190 WO1993000423A1 (en) 1991-06-21 1992-06-18 Iron chelate culture medium additive
EP92913614A EP0593539A1 (de) 1991-06-21 1992-06-18 Additiv für kulturmedium auf der basis von eisenchelaten

Publications (1)

Publication Number Publication Date
EP0593539A1 true EP0593539A1 (de) 1994-04-27

Family

ID=8208780

Family Applications (1)

Application Number Title Priority Date Filing Date
EP92913614A Withdrawn EP0593539A1 (de) 1991-06-21 1992-06-18 Additiv für kulturmedium auf der basis von eisenchelaten

Country Status (5)

Country Link
EP (1) EP0593539A1 (de)
JP (1) JPH06508523A (de)
AU (1) AU2196892A (de)
CA (1) CA2111984A1 (de)
WO (1) WO1993000423A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4330597A (en) 1996-08-30 1998-03-19 Life Technologies, Inc. Serum-free mammalian cell culture medium, and uses thereof
US6767741B1 (en) 1999-08-27 2004-07-27 Invitrogen Corporation Metal binding compounds and their use in cell culture medium compositions
DE60037819T2 (de) * 1999-08-27 2009-01-08 Invitrogen Corp., Carlsbad Metallbindende verbindungen und deren verwendung in zusammensetzungen für zellkulturmedien
US20030096414A1 (en) 2001-03-27 2003-05-22 Invitrogen Corporation Culture medium for cell growth and transfection
CA2417689C (en) * 2002-03-05 2006-05-09 F. Hoffmann-La Roche Ag Improved methods for growing mammalian cells in vitro
ATE359359T1 (de) * 2003-08-08 2007-05-15 Cambridge Antibody Tech Myeloma zellkultur in einem transferrin-freien medium mit niedrigem eisengehalt
GB2404665B (en) 2003-08-08 2005-07-06 Cambridge Antibody Tech Cell culture
AU2005302516A1 (en) 2004-10-29 2006-05-11 Centocor, Inc. Chemically defined media compositions
KR101594046B1 (ko) 2008-01-09 2016-02-15 첼카 게엠베하 개선된 배양 배지 첨가제 및 이를 이용한 방법
RU2663794C2 (ru) * 2011-10-21 2018-08-09 Пфайзер Инк. Добавление железа для улучшения культивирования клеток
EP3778868B1 (de) * 2019-08-16 2022-01-26 UGA Biopharma GmbH Zellkulturmedium zur kultivierung von zellen, verfahren zum kultivieren von zellen und verfahren zur expression von mindestens einem rekombinanten protein in einer zellkultur

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS262822B1 (en) * 1986-10-03 1989-04-14 Kovar Jan Synthetic medium for the cultivation of myelomic cells
NO162160C (no) * 1987-01-09 1989-11-15 Medi Cult As Serumfritt vekstmedium, samt anvendelse derav.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9300423A1 *

Also Published As

Publication number Publication date
AU2196892A (en) 1993-01-25
JPH06508523A (ja) 1994-09-29
WO1993000423A1 (en) 1993-01-07
CA2111984A1 (en) 1993-01-07

Similar Documents

Publication Publication Date Title
Evans et al. Chemically defined media for cultivation of long-term cell strains from four mammalian species
EP0274445B1 (de) Serumfreie Kulturmittelzutat und ihre Verwendung
US5122469A (en) Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
CN101603026B (zh) 适于动物细胞产品生产的无动物来源低蛋白培养基
Jan et al. Peptone, a low-cost growth-promoting nutrient for intensive animal cell culture
Iype Cultures from adult rat liver cells I. Establishment of monolayer cell‐cultures from normal liver
EA023193B1 (ru) Среда для культивирования клеток для экспрессии белков adamts
Heath et al. Methods for increasing monoclonal antibody production in suspension and entrapped cell cultures: biochemical and flow cytometric analysis as a function of medium serum content
CN104822821A (zh) 用于优化灌流细胞培养系统的方法和系统
JP2016052310A (ja) 改良型細胞培養培地
EP0593539A1 (de) Additiv für kulturmedium auf der basis von eisenchelaten
CN1962857A (zh) 一种哺乳动物细胞无血清培养基
Minamoto et al. Development of a serum-free and heat-sterilizable medium and continuous high-density cell culture
CN106399224A (zh) 无血清无蛋白细胞培养基
JPH08508875A (ja) 蛋白分泌細胞の流加回分培養法
JPH09512171A (ja) 無血清培地添加物
NZ229187A (en) Method of production of t-pa from cell culture
US4879222A (en) Method of isolating tumor-secreted products using a novel protein-free medium
JP2016508376A (ja) 組換えタンパク質産生の増加のための製剤及び方法
JPH03254679A (ja) 新規細胞株
JPH0432078B2 (de)
US5602025A (en) Non-tumorigenic cell lines for expression of genes
JP3096737B1 (ja) ヒト・動物細胞培養液
WO2012008920A1 (en) Materials and methods for enhanced iron uptake in cell culture
JPH0510074B2 (de)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19931208

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19980102